|
HRP20140049T1
(hr)
|
2007-01-05 |
2014-02-28 |
University Of Zürich |
Anti beta-amiloid antitijela i njihova upotreba
|
|
CA2853412C
(en)
|
2011-10-28 |
2021-05-04 |
University Of Zurich |
Tdp-43 specific binding molecules
|
|
CA2914831C
(en)
*
|
2013-06-11 |
2022-10-11 |
Paul Scherrer Institut |
Method for determining mutateable ligand-gpcr binding at single amino acid resolution and pairs of mutated ligand and gpcr
|
|
WO2015117088A2
(en)
|
2014-01-31 |
2015-08-06 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Antibody based reagents that specifically recognize neurodegenerative disease related forms of the protein tdp-43
|
|
EP4406549A3
(en)
|
2014-07-29 |
2025-01-08 |
Neurimmune Holding AG |
Human-derived anti-huntingtin (htt) antibodies and uses thereof
|
|
CN104497121A
(zh)
*
|
2014-08-29 |
2015-04-08 |
苏州顺升桥生物科技有限公司 |
淀粉样蛋白tdp-43及其用途
|
|
EP3200825A4
(en)
|
2014-10-03 |
2018-03-21 |
Academia Sinica |
Antibodies against pathological forms of tdp-43 and uses thereof
|
|
WO2016053610A1
(en)
*
|
2014-10-03 |
2016-04-07 |
Academia Sinica |
Antibodies against pathological forms of tdp-43 and uses thereof
|
|
TWI592423B
(zh)
*
|
2014-10-03 |
2017-07-21 |
中央研究院 |
可辨識致病性ｔｄｐ－４３之抗體及其用途
|
|
MA41115A
(fr)
|
2014-12-02 |
2017-10-10 |
Biogen Int Neuroscience Gmbh |
Procédé de traitement de la maladie d'alzheimer
|
|
US10509045B2
(en)
|
2015-05-29 |
2019-12-17 |
University Of Florida Research Foundation, Incorporated |
Methods for diagnosing Huntington's disease
|
|
WO2017111166A1
(ja)
*
|
2015-12-25 |
2017-06-29 |
国立大学法人東京農工大学 |
Ｔｄｐ－４３細胞内存在量関連疾患治療剤
|
|
DK3430397T3
(da)
|
2016-03-14 |
2022-05-02 |
Biogen Int Neuroscience Gmbh |
Antistofafhængig cellemedieret fagocytoseassay til pålidelig måling af optagelse af aggregerede proteiner
|
|
US10940161B2
(en)
|
2016-04-04 |
2021-03-09 |
University Of Florida Research Foundation, Incorporated |
Manipulation of EIF3 to modulate repeat associated non-ATG (RAN) translation
|
|
US20190330318A1
(en)
|
2016-07-25 |
2019-10-31 |
Biogen Ma Inc. |
Anti-hspa5 (grp78) antibodies and uses thereof
|
|
MA47163A
(fr)
|
2016-12-16 |
2019-11-06 |
Biogen Ma Inc |
Facteur 11 de différenciation de croissance activé protéolytiquement stabilisé
|
|
KR102715540B1
(ko)
|
2017-03-14 |
2024-10-08 |
파이브 프라임 테라퓨틱스, 인크. |
산성 pH에서 VISTA에 결합하는 항체
|
|
WO2018195110A1
(en)
|
2017-04-17 |
2018-10-25 |
University Of Florida Research Foundation, Incorporated |
Regolation of ran translation by pkr and eif2a-p pathways
|
|
CA3064785A1
(en)
*
|
2017-05-30 |
2018-12-06 |
The University Of British Columbia |
Epitopes in the rna recognition motif 1 (rrm1) of tdp-43 and misfolding-selective antibodies thereto
|
|
IL272773B2
(en)
|
2017-08-22 |
2024-06-01 |
Biogen Ma Inc |
Pharmaceutical preparations containing anti-amyloid cell antibodies
|
|
JP2020535448A
(ja)
|
2017-09-25 |
2020-12-03 |
ユニバーシティー オブ フロリダ リサーチ ファンデーション， インク． |
Ｒａｎタンパク質の検出のための免役アッセイ
|
|
US11246857B2
(en)
*
|
2017-12-14 |
2022-02-15 |
The Johns Hopkins University |
Anti-fungal inhibitors
|
|
WO2019113711A1
(en)
|
2017-12-14 |
2019-06-20 |
University Of Ottawa |
Exosome packaging and targeted autophagy
|
|
EP3735422A1
(en)
*
|
2018-01-05 |
2020-11-11 |
AC Immune SA |
Misfolded tdp-43 binding molecules
|
|
US12215142B2
(en)
|
2018-03-16 |
2025-02-04 |
National University Corporation Shiga University Of Medical Science |
Antibody fragment degrading and removing abnormal TDP-43
|
|
BR112020019083A2
(pt)
|
2018-03-21 |
2020-12-29 |
Five Prime Therapeutics, Inc. |
Anticorpos, ácido nucleico, composições, célula e métodos para preparar um anticorpo, para tratar câncer, para tratar uma doença infecciosa, para tratar uma inflamação, para a identificação de um anticorpo, para melhorar a eficácia antitumoral de um anticorpo, para melhorar a farmacocinética de um anticorpo, para selecionar um anticorpo, para melhorar a eficácia de anticorpos, para isolar anticorpos, para detectar vista em uma amostra e para tratar câncer
|
|
TW202019398A
(zh)
*
|
2018-06-28 |
2020-06-01 |
張翔毓 |
用於治療或預防構形疾病之方法及藥物篩選方法
|
|
BR112021000303A2
(pt)
|
2018-07-11 |
2021-04-13 |
Five Prime Therapeutics, Inc. |
Anticorpos que se ligam a vista em ph ácido
|
|
CN113508135A
(zh)
|
2018-10-29 |
2021-10-15 |
比奥根Ma公司 |
增强血脑屏障转运的人源化和稳定化的fc5变体
|
|
AU2019399680A1
(en)
*
|
2018-12-14 |
2021-07-15 |
Promis Neurosciences Inc. |
Antibodies to misfolded TDP-43 and methods of use
|
|
KR20220012270A
(ko)
*
|
2019-05-23 |
2022-02-03 |
에이씨 이뮨 에스.에이. |
항-tdp-43 결합 분자 및 이의 용도
|
|
JP7850066B2
(ja)
*
|
2019-08-12 |
2026-04-22 |
セロシア セラピューティクス プロプライアタリー リミティド |
治療のための組成物および方法
|
|
WO2021055880A1
(en)
|
2019-09-20 |
2021-03-25 |
University Of Florida Researchfoundation, Incorporated |
Detection of antibodies against ran proteins from serum and tissue lysates
|
|
GB202004863D0
(en)
*
|
2020-04-02 |
2020-05-20 |
Univ Oxford Innovation Ltd |
Method
|
|
BR112022021604A2
(pt)
|
2020-04-28 |
2022-12-06 |
Sola Biosciences Llc |
Composições e métodos para tratamento de proteinopatias associadas à tdp-43
|
|
CA3176840A1
(en)
*
|
2020-04-29 |
2021-11-04 |
Neil R. Cashman |
Single chain antibodies and intrabodies to misfolded tdp-43 and methods of use
|
|
US20230288432A1
(en)
*
|
2020-07-06 |
2023-09-14 |
The Board Of Regents Of The University Of Texas System |
Tdp-43 biosensor cell lines
|
|
EP4196162A1
(en)
*
|
2020-08-14 |
2023-06-21 |
AC Immune SA |
Humanized anti-tdp-43 binding molecules and uses thereof
|
|
JP2023551542A
(ja)
|
2020-11-30 |
2023-12-08 |
エニグマ バイオインテリジェンス，インコーポレイテッド |
アルツハイマー病の非侵襲的評価
|
|
MX2023008744A
(es)
|
2021-01-29 |
2023-10-02 |
Illimis Therapeutics Inc |
Molecula de fusion que tiene actividad no inflamatoria inductora de la fagocitosis.
|
|
CN112920264B
(zh)
*
|
2021-02-08 |
2022-07-05 |
武汉大学 |
Tdp-43蛋白的o-糖基化突变体及其应用
|
|
JP6961278B1
(ja)
*
|
2021-03-10 |
2021-11-05 |
国立研究開発法人量子科学技術研究開発機構 |
生体試料中のｔｄｐ−４３を測定する方法及び装置
|
|
CA3221254A1
(en)
*
|
2021-05-27 |
2022-12-01 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating proteinopathies
|
|
US20230107901A1
(en)
*
|
2021-10-01 |
2023-04-06 |
University Of Utah Research Foundation |
Pathologic tdp-43 as a biomarker for the diagnosis of tdp-43 proteinopathy
|
|
WO2023099788A1
(en)
|
2021-12-03 |
2023-06-08 |
Neurimmune Ag |
Novel potency assay for antibody-based drugs and useful means therefor
|
|
CR20240378A
(es)
|
2022-02-16 |
2024-10-03 |
Ac Immune Sa |
Moléculas de unión anti -tdp-43 humanizadas y usos de las mismas
|
|
EP4504775A1
(en)
*
|
2022-04-08 |
2025-02-12 |
AC Immune SA |
Anti-tdp-43 binding molecules
|
|
WO2023205579A1
(en)
*
|
2022-04-18 |
2023-10-26 |
The Regents Of The University Of California |
Compositions and methods for disrupting pathological aggregates
|
|
EP4497826A4
(en)
|
2022-04-22 |
2026-03-25 |
Univ Niigata |
TDP-43 AGGREGATION SUPPRESSANT AND PHARMACEUTICAL COMPOSITION
|
|
WO2024184494A1
(en)
|
2023-03-08 |
2024-09-12 |
Ac Immune Sa |
Anti-tdp-43 binding molecules and uses thereof
|
|
EP4716540A1
(en)
*
|
2023-06-20 |
2026-04-01 |
The Trustees of Dartmouth College |
Chimeric antigen receptors (cars) targeting tdp43, tregs expressing said cars, and use thereof for the treatment of als, ftd and ad
|
|
KR102859015B1
(ko)
*
|
2023-07-20 |
2025-09-12 |
충북대학교 산학협력단 |
ｃＡｂｌ에 의한 ＴＤＰ４３의 특이적 인산화 분석을 통한 신경퇴행성 질환을 진단하는 방법 및 이를 이용한 신경퇴행성 질환의 치료제 스크리닝 방법
|
|
CN116875738A
(zh)
*
|
2023-07-24 |
2023-10-13 |
山东省农业科学院畜牧兽医研究所 |
一种鉴定牛tdp-43基因启动子活性区域的方法
|
|
AR133828A1
(es)
*
|
2023-09-15 |
2025-11-05 |
Prothena Biosciences Ltd |
Anticuerpos anti-tdp-43 y sus usos
|
|
WO2025186332A1
(en)
|
2024-03-05 |
2025-09-12 |
Ac Immune Sa |
Vectorized anti-tdp-43 antibodies
|
|
WO2026013218A1
(en)
|
2024-07-10 |
2026-01-15 |
Ac Immune Sa |
Anti-tdp-43 vectors, binding molecules and uses thereof
|
|
KR20260044274A
(ko)
*
|
2024-09-23 |
2026-04-02 |
주식회사 피플바이오 |
Tdp-43에 특이적으로 결합하는 항체 및 이의 용도
|
|
CN119331085B
(zh)
*
|
2024-10-16 |
2025-03-14 |
中国科学院合肥物质科学研究院 |
沙贝冠状病毒广谱中和抗体及其应用
|